| George Arnold Alexander III, MPA |
| Partner, ALEX Companies |
| Associate Broker, Alexander Tiffany Southwest, LLC |
| Licensed Broker in TX, CO, NC, AL |
| [email protected] · +1 713.918.9951 |
| TREC Information About Brokerage Services · TREC Consumer Protection Notice |
AI in Healthcare
2026-10-07
Collateral held back: the slide deck and the video for this post still show a figure that could not be verified against the cited source, so they are withheld until they are rebuilt. The text above and the source link below are unaffected.
What if the most critical AI in healthcare isn’t in the algorithm—but in the policy room?
The FDA has authorized 1,500 AI medical devices, yet evidence for most is still catching up. This isn’t just a tech gap—it’s a governance crisis. As AI tools enter clinics faster than evidence can follow, the real bottleneck isn’t innovation—it’s oversight. The Clinical Trial Vanguard reports that 1,500 AI medical devices have received FDA approval as of October 7, 2026, with most lacking robust real-world validation. This is not a failure of engineering, but of policy architecture. Without mandatory, standardized post-market evaluation, we risk deploying tools that are unproven, unverified, and potentially harmful. The future of AI in medicine depends not on faster algorithms, but on smarter rules. How do we build a global governance framework that keeps pace with AI acceleration? Let’s discuss.
Source: The Clinical Trial Vanguard · Published October 07, 2026
URL: https://news.google.com/rss/articles/CBMi1wFBVV95cUxQc05peVRmU0plUzM0Y0tXTkdJS1ZrU1hjZHh6eFlZbmFDdHFMczhoLWJNSXBkbTJLSm5OVjVYTjI5X0MxVHVJbDRKY2tXb3FnZWxablNZaXZMV1h4bWliMW1xS2lIMEptMlVpbXotVjRWWXFIenVhazlzcUU2eEhCekhHRWYxZlNNR1F5anRzNlVOS0M2aUQ5by1McFRwM1ZBX1NZckVtZjE2Rkh2V3dvak5ybUVTdWpFSGNzczZ1NEMtQnpSRV9uXzUxakg1VWxVSEd3MVNndw?oc=5
View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups
If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.
Licensed by the Texas Real Estate Commission. Broker: Alexander Tiffany Southwest, LLC · License #565194-BB.
Diane Hart Alexander, Chair & CEO, ALEX Companies · Designated Broker · #574877-B · George Arnold Alexander III, Partner, ALEX Companies · Associate Broker · #574878-B
Texas Real Estate Commission Information About Brokerage Services · TREC Consumer Protection Notice · trec.texas.gov
Diane Hart Alexander, Chair & CEO, ALEX Companies · Designated Broker · #574877-B · George Arnold Alexander III, Partner, ALEX Companies · Associate Broker · #574878-B
Texas Real Estate Commission Information About Brokerage Services · TREC Consumer Protection Notice · trec.texas.gov